Limonene, (+/-)-

DB19146InvestigationalSmall molecule

Limonene, (+/-)- is under investigation in clinical trial NCT05525260 (Limonene for Pulmonary Nodule Chemoprevention).

Mechanism: Pharmacologically active on Adenosine receptor A2b and Adenosine receptor A2a
Curator reviewed
Formula / weight: C₁₀H₁₆ · 136.238 g/mol (avg)
Also known as: (+/-)-1-methyl-4-(1-methylethenyl)cyclohexene · (+/-)-limonene · 1-methyl-4-(1-methylethenyl)cyclohexene · 4-isopropenyl-1-methyl-1-cyclohexene · Cajeputene
Code names: NSC-21446 · NSC-844

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyXMGQYMWWDOXHJM-UHFFFAOYSA-NSMILESCC(=C)C1CCC(C)=CC1

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Limonene, (+/-)-, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.